Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors

INTRODUCTION: In this study, we aim to report the outcome of COVID-19 in chronic myeloid leukemia (CML) patients receiving tyrosine kinase inhibitor (TKI). METHOD: The data of 16 laboratory-confirmed COVID-19 patients with CML receiving TKI and age, gender, and comorbid disease matched COVID-19 pati...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:J Oncol Pharm Pract
Κύριοι συγγραφείς: Başcı, Semih, Ata, Naim, Altuntaş, Fevzi, Yiğenoğlu, Tuğçe Nur, Dal, Mehmet Sinan, Korkmaz, Serdal, Namdaroğlu, Sinem, Baştürk, Abdülkadir, Hacıbekiroğlu, Tuba, Doğu, Mehmet Hilmi, Berber, İlhami, Dal, Kürşat, Erkurt, Mehmet Ali, Turgut, Burhan, Çağlayan, Murat, Ayvalı, Mustafa Okan, Çelik, Osman, Ülgü, Mustafa Mahir, Birinci, Şuayip
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: SAGE Publications 2020
Θέματα:
Original Articles
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7506180/
https://ncbi.nlm.nih.gov/pubmed/32854573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1078155220953198
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια